Analyze Diet

Topic:Disease Prevention

Disease prevention in horses encompasses strategies and practices aimed at minimizing the occurrence and spread of infectious and non-infectious diseases within equine populations. These practices include vaccination programs, biosecurity measures, and regular health monitoring. Vaccination helps to stimulate the horse's immune system to protect against specific pathogens, while biosecurity measures, such as quarantine and sanitation, reduce the risk of disease transmission. Regular health monitoring, including physical examinations and diagnostic testing, aids in early detection and management of potential health issues. This page compiles peer-reviewed research studies and scholarly articles that explore various methods and their effectiveness in preventing diseases in horses, as well as the development and implementation of prevention programs in different equine settings.
Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge.
Archives of virology. Supplementum    May 4, 2004   Issue 18 221-230 doi: 10.1007/978-3-7091-0572-6_20
Minke JM, Siger L, Karaca K, Austgen L, Gordy P, Bowen R, Renshaw RW, Loosmore S, Audonnet JC, Nordgren B.An ALVAC (canarypoxvirus)-based recombinant (vCP2017) expressing the prM and E genes derived from a 1999 New York isolate of West Nile virus (WNV) was constructed and assessed for its protective efficacy in horses in two different experiments. In the first trial, a dose titration study was conducted to evaluate both serum neutralising antibody responses to WNV and duration of immunity. In the second trial the onset of protection was determined. Twenty-eight adult horses received two doses of vCP2017 administered intramuscularly at 5-week intervals and sixteen horses comprised age-matched non-v...
Equine hyperlipaemia: a review.
Australian veterinary journal    April 20, 2004   Volume 82, Issue 3 136-142 doi: 10.1111/j.1751-0813.2004.tb12636.x
Hughes KJ, Hodgson DR, Dart AJ.No abstract available
Exotic Animal Diseases Bulletin.
Australian veterinary journal    April 20, 2004   Volume 82, Issue 1-2 16-17 doi: 10.1111/j.1751-0813.2004.tb14623.x
No abstract available
Design and organization of an equine intensive care unit.
The Veterinary clinics of North America. Equine practice    April 6, 2004   Volume 20, Issue 1 1-10 doi: 10.1016/j.cveq.2003.11.004
Hardy J.Careful planning and design of a new ICU are warranted to maximize use of the facility, minimize the risk of hospital-acquired infection, and improve overall patient outcome. In addition, personnel satisfaction improves with an improved work environment. A functional equine ICU is also tailored to the geographic area, local needs of the practice, and anticipated investment.
Prospects for vaccination against equine grass sickness.
Equine veterinary journal    March 25, 2004   Volume 36, Issue 2 186-191 doi: 10.2746/0425164044868710
Hedderson EJ, Newton JR.Their is both historical and modern scientific evidence to support the hypothesis that equine grass sickness (EC'S) is caused by a toxico-infectious form of botulism involving a Clostridium botulism type C toxin 1114 is produced locally within the gastrointestinal tract of affected horses (Toc her et al. 1923: Tneher 1924: Hunter a aL 1999: Hunter and anion 2001: McCarthy 2002: McCarthy a aL 201)4a1. This report concerns a meeting convened to review the current state of knowledge and possible strategies for vaccination against EGS. including historical. clinical and pathological aspects of the...
Why are certain premises at increased risk of equine grass sickness? A matched case-control study.
Equine veterinary journal    March 25, 2004   Volume 36, Issue 2 130-134 doi: 10.2746/0425164044868594
McCarthy HE, French NP, Edwards GB, Miller K, Proudman CJ.Equine grass sickness (EGS) occurs repeatedly on certain premises over time. Few studies have sought, or identified, the determinants of this phenomenon in order to inform advice on disease prevention strategies. Objective: Premises-level risk factors are important determinants of whether EGS occurs. Methods: A matched case-control study was undertaken. Sixty premises giving rise to one or more histologically confirmed case of EGS and 120 time-matched control premises were sampled. Data were collected on pasture management, soil nutrient content, pasture nutrient content and local weather cond...
Equine grass sickness is associated with low antibody levels to Clostridium botulinum: a matched case-control study.
Equine veterinary journal    March 25, 2004   Volume 36, Issue 2 123-129 
McCarthy HE, French NP, Edwards GB, Poxton IR, Kelly DF, Payne-Johnson CE, Miller K, Proudman CJ.Equine grass sickness is a high mortality disease which, despite many years of investigation, is of unknown aetiology. Recent findings indicating that the disease is associated with Clostridium botulinum require support from an epidemiological study that recognises and controls for potential confounders, e.g. age, time of year and premises. Objective: EGS is associated with low antibody levels to C. botulinum antigens. Methods: A matched case-control study was conducted. Data were collected from 66 histologically confirmed cases of EGS and 132 premises-matched control horses. The probability o...
Descriptive epidemiology of fractures occurring in British Thoroughbred racehorses in training.
Equine veterinary journal    March 25, 2004   Volume 36, Issue 2 167-173 doi: 10.2746/0425164044868684
Verheyen KL, Wood JL.Musculoskeletal injury is the major cause of days lost from training and wastage in Thoroughbred racehorses. Little scientific information is available on the majority of injuries occurring in training. Objective: To estimate the incidence of fractures in British racehorses in training and describe the occurrence of different fracture types and bones involved. Methods: Thirteen UK racehorse trainers participated in a prospective study, providing data on horses in their care for 2 years. Details on horses, their daily exercise and fracture occurrence were recorded. Results: A total of 1178 hors...
An epidemiological study of risk factors associated with the recurrence of equine grass sickness (dysautonomia) on previously affected premises.
Equine veterinary journal    March 25, 2004   Volume 36, Issue 2 105-112 doi: 10.2746/0425164044868639
Newton JR, Hedderson EJ, Adams VJ, McGorum BC, Proudman CJ, Wood JL.The reasons why equine grass sickness (EGS) recurs on premises are unknown and, consequently, practical methods for reducing the risk of recurrence are not available. Objective: To identify risk factors associated with recurrence of EGS on premises and to gain possible insights into the pathogenesis of the disease. Methods: Data on disease history and risk factors were collected by postal questionnaire from premises with EGS cases between 1st January 1997 and 31st December 2001. Data on variation in rates of recurrence of EGS for different risk factors were analysed using Poisson regression an...
Effects of ketanserin on hypergranulation tissue formation, infection, and healing of equine lower limb wounds.
The Canadian veterinary journal = La revue veterinaire canadienne    March 18, 2004   Volume 45, Issue 2 144-149 
Engelen M, Besche B, Lefay MP, Hare J, Vlaminck K.The objective of this multicentre, randomized, controlled field study was to determine the efficacy of ketanserin gel in preventing exuberant granulation tissue formation (hypergranulation) and infection in equine lower limb wounds. Horses and ponies (n = 481) with naturally occurring wounds were randomized to either topical treatment with ketanserin gel (n = 242) or a positive control (Belgium, Germany: ethacridin lactate solution, n = 120; France, United Kingdom: malic, benzoic, and salicylic acid [MBS] cream, n = 119). Treatment continued until the wound healed (success), formed hypergranul...
Eastern tent caterpillars (Malacosoma americanum) cause mare reproductive loss syndrome.
Journal of insect physiology    March 17, 2004   Volume 50, Issue 2-3 185-193 doi: 10.1016/j.jinsphys.2003.11.008
Webb BA, Barney WE, Dahlman DL, DeBorde SN, Weer C, Williams NM, Donahue JM, McDowell KJ.A new equine abortigenic disease, mare reproductive loss syndrome (MRLS), was recognized and significantly impacted the Ohio Valley in the springs of 2001 and 2002. MRLS caused approximately 330 million US dollars in losses in 2001. An epidemiological investigation of MRLS associated occurrence of the disease with exposure to eastern tent caterpillars (M. americanum). This work investigates the epidemiological association between M. americanum and MRLS to determine if this association was correlative or causative. A pilot study and simulated exposure to M. americanum and their excreta on pastu...
The current challenges of dourine: difficulties in differentiating Trypanosoma equiperdum within the subgenus Trypanozoon.
Revue scientifique et technique (International Office of Epizootics)    March 10, 2004   Volume 22, Issue 3 1087-1096 doi: 10.20506/rst.22.3.1460
Zablotskij VT, Georgiu C, de Waal T, Clausen PH, Claes F, Touratier L.During its 20th annual meeting in Paris in May 1999, the OIE (World organisation for animal health) Ad Hoc Group on Non-Tsetse Transmitted Animal Trypanosomoses expressed the following concerns about dourine: the discrepancies in some of the results of the complement fixation test (CFT), which is the only international diagnostic test officially recognised by the International Organisation for the Transportation of Equidae; the persistence of suspected cases of dourine in some Asian, European and African countries; the impossibility of differentiating Trypanosoma equiperdum from Trypanosoma ev...
Prevalence of antibody to Japanese encephalitis virus nonstructural 1 protein among racehorses in Japan: indication of natural infection and need for continuous vaccination.
Vaccine    March 9, 2004   Volume 22, Issue 9-10 1097-1103 doi: 10.1016/j.vaccine.2003.10.001
Konishi E, Shoda M, Kondo T.Japanese encephalitis virus (JEV) causes fatal diseases in equines as well as humans. In Japan, racehorses are vaccinated with inactivated JE vaccine every year and no equine JE cases have been reported since 1986. However, the current reduction in JEV activity in nature has raised an argument against the requirement of continuous vaccination. Here, we studied natural infection rates in racehorses to address the issue. To identify naturally-infected individuals from vaccinated populations, we used an immunostaining method for detecting antibodies to JEV nonstructural 1 (NS1) protein. A total o...
[Vision through cooperation between horse clinics].
Tijdschrift voor diergeneeskunde    February 24, 2004   Volume 129, Issue 3 98-99 
van Oijen PW, Cornelissen BP.No abstract available
Updating equine influenza strains in a combined equine influenza and herpesvirus vaccine.
Veterinary journal (London, England : 1997)    February 21, 2004   Volume 167, Issue 2 118-120 doi: 10.1016/S1090-0233(03)00034-0
Cullinane AA.No abstract available
Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).
Veterinary journal (London, England : 1997)    February 21, 2004   Volume 167, Issue 2 150-157 doi: 10.1016/S1090-0233(03)00028-5
Heldens JG, Pouwels HG, van Loon AA.It has been recommended that modern equine influenza vaccines should contain an A/equi-1 strain and A/equi-2 strains of the American and European-like subtype. We describe here the efficacy of a modern updated inactivated equine influenza-herpesvirus combination vaccine against challenge with a recent American-like isolate of equine influenza (A/equine-2/Kentucky/95 (H3N8). The vaccine contains inactivated Influenza strains A-equine-1/Prague'56, A-equine-2/Newmarket-1/'93 (American lineage) and A-equine-2/ Newmarket-2/93 (Eurasian lineage) and inactivated EHV-1 strain RacH and EHV-4 strain V22...
Equine genomics: galloping to new frontiers.
Cytogenetic and genome research    February 19, 2004   Volume 102, Issue 1-4 184-188 doi: 10.1159/000075746
Chowdhary BP, Bailey E.Analysis of the horse genome is proceeding at a rapid pace. Within a short span of 6-7 years, approximately 1,500 markers have been mapped in horse, of which at least half are genes/ESTs. Health, performance and phenotypic characteristic are of major concern/interest to horse breeders and owners. Current efforts to analyze the equine genome are primarily aimed at developing critical resources (including an advanced gene map) that could readily be used in the near future to i) identify genes and mutations responsible for inherited equine diseases/disorders and to formulate approaches for accura...
Anthelmintic resistance and use of anthelmintics in horses.
The Veterinary record    February 6, 2004   Volume 154, Issue 3 96 
Vercruysse J, Hennessy D, Jacobs D, Donoghue A, Krecek T.No abstract available
Anthelmintic resistance and use of anthelmintics in horses.
The Veterinary record    February 5, 2004   Volume 154, Issue 2 62-64 
Abbott E, Bairden K, Barger I, Cobb R, Kennedy T, Reinemeyer C.No abstract available
Anthelmintic resistance and use of anthelmintics in horses.
The Veterinary record    February 5, 2004   Volume 154, Issue 2 64 
Chandler K.No abstract available
Treatment and prevention of intestinal parasite-associated disease.
The Veterinary clinics of North America. Equine practice    January 27, 2004   Volume 19, Issue 3 791-806 doi: 10.1016/j.cveq.2003.08.003
Love S.Since 1917, only 11 new endoparasiticides have been developed for the horse, of which five chemical classes are in common use. The selection pressure of frequent administration of deworming doses for parasite control programs has been associated with the development of resistance of small strongyle parasites to the effects of benzimidazoles and pyrantel salts. Against the background of the inevitability of the occurrence of ivermectin/moxidectin resistance, responsible use of equine anthelmintics based on the clinical pharmacology of the compounds and the biology/epidemiology of intestinal par...
Treatment and prevention of equine gastric ulcer syndrome.
The Veterinary clinics of North America. Equine practice    January 27, 2004   Volume 19, Issue 3 575-597 doi: 10.1016/j.cveq.2003.08.012
Buchanan BR, Andrews FM.EGUS is a common problem in horses and foals. Acids are the important causative factors and current therapy targets the suppression of gastric HCl and creation of a permissive environment for ulcer healing. Diagnosis is based on history, clinical signs, gastroscopy, and response to treatment. Of the products available, only GastroGard (FDA approved) and ranitidine have been shown to be efficacious in the treatment of EGUS. Ranitidine is often associated with treatment failure as a result of incorrect dosing and lack of owner compliance, because of the three times daily dosing required. Also, E...
Prevention and treatment of gastrointestinal adhesions.
The Veterinary clinics of North America. Equine practice    January 27, 2004   Volume 19, Issue 3 741-763 doi: 10.1016/j.cveq.2003.08.014
Eggleston RB, Mueller PO.As with many aspects of clinical medicine, there is yet to be a single or definitive cure for postoperative adhesion formation. Current methods of prevention target risk factors predisposing horses to adhesion formation. Systemic pharmacologic therapies, such as antimicrobials, nonsteroidal anti-inflammatory drugs, Salmonella antiserum, and hyperimmune plasma, help to reduce abdominal inflammation and minimize the effects of endotoxemia. Intra-abdominal or systemic heparin aids in enhancing peritoneal fibrinolysis. Prokinetic therapy promotes early postoperative return of intestinal motility, ...
Prevention and treatment of thrombosis, phlebitis, and laminitis in horses with gastrointestinal diseases.
The Veterinary clinics of North America. Equine practice    January 27, 2004   Volume 19, Issue 3 779-790 doi: 10.1016/j.cveq.2003.08.002
Divers TJ.Organ thrombosis and laminitis are life-threatening complications in horses with acute gastrointestinal disease, especially those diseases that cause disruption of the protective mucosal barrier. Prevention of these complications should be a high priority when treating horses with gastrointestinal diseases because even with proper and intensive treatments, laminitis or organ thrombosis may not be curative. Preventative therapy should include expedient and appropriate treatment of the primary disease, normalization of tissue perfusion and oxygenation, and inhibition of gut-derived toxins or the...
[Structure and clinical implications of the coronary horn stratification with special consideration of horn maturation, aging and decay processes in the equine hoof].
DTW. Deutsche tierarztliche Wochenschrift    December 19, 2003   Volume 110, Issue 11 438-444 
König B, Budras KD.The three superimposing strata of the coronet and the ageing process and decay of the hoof horn were studied in 56 fore hooves of 28 domestic horses of different age and sex. Except for horn clefts at the weight bearing margin, their hooves did not show any signs of pathological changes. Their hooves did not show any signs of pathological changes. The investigation comprised the analysis of the structure and the mechanical-physical measurement of horn hardness. The own results showed that the functional and clinical importance of the three strata of the coronet concerns the absorption and dist...
Equine vaccine for West Nile virus.
Developments in biologicals    December 18, 2003   Volume 114 221-227 
Ng T, Hathaway D, Jennings N, Champ D, Chiang YW, Chu HJ.To meet the urgent need of controlling West Nile virus (WNV) infection in the equine population, we have developed a killed WNV vaccine. A dose titration study in horses was first conducted to evaluate serum neutralization antibody responses against WNV in these animals. Horses were vaccinated intramuscularly twice with the test vaccine at low, medium and high dose, three weeks apart. Serum samples were collected periodically and were measured for serum neutralizing antibody using a plaque reduction neutralization test. Significant increases in serum neutralizing antibody were detected in all ...
[Glanders–an eradicable disease–or a threat?].
Casopis lekaru ceskych    December 6, 2003   Volume 140, Issue 24 752-754 
Pospísil L.Glanders (malleus), attacking equids and transmissible to humans, does not occur in our geographical area any more, but world-wide eradication has not yet been achieved. Cases of glanders have been reported from India, Iraq, Mongolia and China and in 2001 also from South America. The disease is caused by Burkholderia mallei (earlied known as Bacillus, Pfeiferella, Loefflerella, Malleomyces, Actinobacillus, or Pseudomonas mallei). The continual interest of microbiologists in the causative agents indicates that glanders cannot be regarded as a closed historic episode. Occupational infections of ...
Anthelmintic resistance and use of anthelmintics in horses.
The Veterinary record    December 5, 2003   Volume 153, Issue 20 636 
Coles GC, Eysker M, Hodgkinson J, Matthews JB, Kaplan RM, Klei TR, Sangster NC.No abstract available
Equine passports.
The Veterinary record    December 3, 2003   Volume 153, Issue 19 604 
Robinson HC.No abstract available
Acquired resistance of horses to Amblyomma cajennense (Fabricius, 1787) ticks.
Veterinary parasitology    November 26, 2003   Volume 117, Issue 4 271-283 doi: 10.1016/j.vetpar.2003.09.004
Castagnolli KC, de Figueiredo LB, Santana DA, de Castro MB, Romano MA, Szabó MP.Acquired immunity of horses to larvae, nymphs and adults of the Amblyomma cajennense tick was evaluated through three consecutive experimental infestations of tick-bite naïve hosts. Data from these infestations were compared to those from field-sensitized horses and donkeys. It was observed that tick-bite naïve horses developed a low level of resistance after two infestations as shown by a significant decrease in larval yield and a tendency for lower engorged weight of nymphs during third infestation. Ticks fed on field-sensitized horses had a similar biological performance to that observed ...
1 66 67 68 69 70 119